Institutional & Family Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Institutional & Family Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$678	Buy	+18	New	+$758	﹤0.01%	679

Other funds holding SWTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Institutional & Family Asset Management's SWTX Position: Q2 2024 in Review

Institutional & Family Asset Management opened a new position in SpringWorks Therapeutics (SWTX) in Q2 2024: 18 shares worth $678. The stake represents ﹤0.01% of the portfolio and ranks #679 among its holdings.

209 funds tracked by Wall St. Rank hold SWTX as of Q2 2024.

Institutional & Family Asset Management held 18 shares of SpringWorks Therapeutics worth $678 as of Q2 2024.
SpringWorks Therapeutics was a new Institutional & Family Asset Management position in Q2 2024.
SpringWorks Therapeutics made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #679 holding.
209 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.